Valeria Catena

447 citations
10 papers · 203 indexed · h-index 8
Topics
Ubiquitin and proteasome pathways (3 papers)Multiple Myeloma Research and Treatments (3 papers)interferon and immune responses (2 papers)
Partner nations
ItalyGermanyMalaysia

In The Last Decade

Valeria Catena

10 papers receiving 200 citations

Peers

Valeria Catena
Comparison fields: 5 of 51
  • Molecular Biology 162
  • Cancer Research 45
  • Oncology 42
  • Immunology 27
  • Epidemiology 20
Replace Yiliang Wei with:
Yiliang Wei United States
Candace J. Poole United States
Laurensia Yuniati Netherlands
Janson W.T. Tse Australia
Yu Shen China
Geraldine Cayanan United States
Domenico Sardella Italy
Joshua P. Plotnik United States
Joanna Fares France
Morvarid Farhang Ghahremani Belgium
Valeria Catena relative to Yiliang Wei United States Yiliang Wei's profile →
Citations per field
00.5×3.6×
Yiliang Wei · 1×
Citations per year

Countries citing papers authored by Valeria Catena

Since Specialization
Citations

This map shows the geographic impact of Valeria Catena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeria Catena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeria Catena more than expected).

Fields of papers citing papers by Valeria Catena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valeria Catena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeria Catena. The network helps show where Valeria Catena may publish in the future.

Co-authorship network of co-authors of Valeria Catena

This figure shows the co-authorship network connecting the top 25 collaborators of Valeria Catena. A scholar is included among the top collaborators of Valeria Catena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valeria Catena. Valeria Catena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 1
2 16
3 4
4 13
5 18
6 80
7 21
8 21
9 13
10 16

About Valeria Catena

Valeria Catena is a scholar working on Hematology, Cell Biology and Cancer Research, having authored 10 papers that have together received 203 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Multiple Myeloma Research and Treatments (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (45 citations), Molecular Biology (162 citations) and Hematology (18 citations). Valeria Catena has collaborated with scholars based in Italy, Germany and Malaysia. Frequent co-authors include Maurizio Fanciulli, Tiziana Bruno, Francesca De Nicola, Simona Iezzi, Cristina Sorino, Aristide Floridi, Claudio Passananti, Giovanni Blandino, Matteo Pallocca and Frauke Goeman. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026